Dr. Min Wu currently serves as Chief Business Development Officer at SciClone Pharmaceuticals. Dr. Wu has more than 20 years of experience in the biotech and pharmaceutical industry. Prior to joining SciClone Group, she served as CBO at Therorna, Managing Director of Fosun Health Fund and as executive director at the Asia Pacific Innovation Hub of MSD. Dr. Wu also took various leadership roles in BD functions at Amgen Asia R&D Center and Roche including Partnering, Alliance and Portfolio Management.

Dr. Wu received her Ph.D. in computational biology and chemistry from New York University. She conducted post-doctoral research at Pfizer and subsequently worked as Principal Scientist at GlaxoSmithKline. She obtained her MBA from University of Manchester, UK.